ThermoGenesis Gains SFDA Approval for Stem Cell Processing Device

ThermoGenesis, a US company that makes stem cell processing and storage devices, said the SFDA approved its BioArchive system for marketing and sales in China. The BioArchive System is an automated cryogenic device that is used for cryopreserving and archiving blood stem cells from umbilical cords for transplant. The company already has three stem cell banks in China as customers. More details.... Stock Symbol:   (NSDQ: KOOL) Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.